Read more - Rhenman & Partners

PRESS RELEASE, 24 April 2015
Rhenman Healthcare Equity L/S awarded two prizes at Nordic
Hedge Awards: Best Nordic Equity Focused Hedge Fund 2014
and Best Performing Nordic Hedge Fund 2014
Since inception in June 2009, the Fund has returned a total of +349%, which
translates to 30% annualised
The Rhenman Healthcare Equity L/S, which invests in listed companies
primarily in pharmaceuticals, medical technology, biotechnology and
services, was awarded Best Nordic Equity Focused Hedge Fund 2014
and Best Performing Nordic Hedge Fund 2014 at the Annual Nordic
Hedge Awards 2014, which is held to commend fund excellence in the
Nordic hedge fund industry.
”This is the most prestigious award in the Nordic hedge fund space, and we are
especially happy to win the category Best Equity Focused Hedge Fund for the third
consecutive year. The universe in 2014 consisted of 161 hedge funds in total so it’s
consequently a very competitive market, and it’s therefore very gratifying that our
experienced investment team fair so well”, said Carl Grevelius, Founding Partner and
Head of Marketing.
“The recognition confirms the importance of our unique investment process which
includes a close cooperation with a Scientific Advisory Board consisting of a number
of respected Professors each with over 30 years’ experience. The healthcare sector
constitutes more than 10% of the total global equity market capitalisation which gives
the fund many interesting investment opportunities to choose from,” said Carl
Grevelius.
Since inception in June 2009, the fund has returned +349% net of fees. The annual
returns of 2013 and 2014 were +55% and +43% respectively.
“We have initiated a soft-close procedure and expect to soft close the fund in October
2015. Existing shareholders can top-up and redeem on a monthly basis until fund
AUM reaches EUR 1bn. Thereafter no additional investments will be allowed.
Currently AUM stands at EUR 530m”, said Grevelius.
For more information, please contact:
Carl Grevelius, Head of Sales & Marketing / Founding Partner
Phone: +46 8 459 88 83
E-mail: [email protected]
www.rhepa.com
About Rhenman & Partners
Rhenman & Partners Asset Management is a Stockholm-based Fund Manager
focusing on the healthcare sector. The company's assets under management amount
to over EUR 530m. Rhenman & Partners was founded in 2008 by a trio with
extensive experience of the asset management sector, as well as an unrivalled track
record in the healthcare sector. Henrik Rhenman has over 20 years experience of
managing successful healthcare funds.
The Rhenman Healthcare Equity L/S fund is unique in that it is supported by a
Scientific Advisory Board composed of eminent professors, each with over 30 years
in their field. The Group has access to a wide network of scientists and experts at
several recognized institutions worldwide, including the Karolinska Institute.
The fund has a long term investment horizon and a diversified portfolio of around 6080 core positions. Whilst trading around positions the fund remains diversified across
subsectors, company size and geographies to lower volatility.
For more information, please visit www.rhepa.com
Rhenman Healthcare Equity L/S – Performance (EUR, Net of fees) –
Outstanding performance in a complex market.
Since inception
YTD 2014 (March)
2013
2012
2011
2010
2009
+ 349%
+ 27%
+ 43%
+ 18%
+ 10%
+ 8%
+ 13%